0.4787
price down icon0.06%   -0.0003
 
loading
Schlusskurs vom Vortag:
$0.479
Offen:
$0.471
24-Stunden-Volumen:
370.10K
Relative Volume:
0.03
Marktkapitalisierung:
$21.17M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-2.3935
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
-0.79%
1M Leistung:
+7.65%
6M Leistung:
-63.46%
1J Leistung:
-83.77%
1-Tages-Spanne:
Value
$0.4675
$0.50
1-Wochen-Bereich:
Value
$0.466
$0.539
52-Wochen-Spanne:
Value
$0.2813
$3.27

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Firmenname
Harvard Bioscience Inc
Name
Telefon
(508) 893-8999
Name
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Mitarbeiter
355
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
0.4787 23.34M 106.79M -8.73M 10.81M -0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
477.78 168.51B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
193.13 55.46B 21.39B 1.59B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.08 42.41B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
281.71 41.63B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
238.74 17.33B 2.90B 467.20M 306.90M 6.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-09 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2023-03-10 Hochstufung The Benchmark Company Speculative Buy → Buy
2021-01-07 Hochstufung The Benchmark Company Speculative Buy → Buy
2020-12-09 Eingeleitet Northland Capital Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-07-08 Herabstufung Janney Buy → Neutral
2018-01-24 Bestätigt Janney Buy
2018-01-23 Bestätigt The Benchmark Company Buy
2016-11-17 Eingeleitet Singular Research Buy
2015-07-28 Eingeleitet The Benchmark Company Buy
Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

pulisher
09:29 AM

Harvard Bioscience 2025 Q2 Earnings Narrows Losses with 22% Drop in Net Loss - AInvest

09:29 AM
pulisher
03:18 AM

Harvard Bioscience: Q2 Earnings Snapshot - Norwalk Hour

03:18 AM
pulisher
03:16 AM

Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada

03:16 AM
pulisher
12:00 PM

Harvard Bioscience Reports Q2 2025 Financial Results - TipRanks

12:00 PM
pulisher
Aug 11, 2025

Harvard Bioscience Q2 2025: Unpacking Contradictions in NIH Funding, Refinance Terms, and China Market Outlook - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Amends Credit Agreement with Lenders - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Delivers Steady Results And Eyes Growth Ahead - Finimize

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Delivers Steady Results And Improved Cash Flow - Finimize

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Q2 2025 Earnings Call Transcript - MarketBeat

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience: Navigating Debt and Innovation in the Biotech Tools Sector - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Aug 11, 2025
pulisher
Aug 11, 2025

Earnings call transcript: Harvard Bioscience Q2 2025 results show mixed signals - Investing.com Nigeria

Aug 11, 2025
pulisher
Aug 11, 2025

Transcript : Harvard Bioscience, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges - Investing.com Canada

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience's Q2 2025 Performance: A Strategic Turnaround Amid Debt Refinancing Challenges - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Reports Q2 Earnings Beat, Initiates Q3 Outlook - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Tops Q2 Revenue Views - The Motley Fool

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Q2 revenue meet estimates - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Q2 2025 Financial Results - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewswire

Aug 11, 2025
pulisher
Aug 11, 2025

Harvard Bioscience Q2 Earnings: Revenue Beats Guidance as New CEO Charts Turnaround Path - Stock Titan

Aug 11, 2025
pulisher
Aug 11, 2025

Will Harvard Bioscience Inc. benefit from macro trendsFree High Conviction Intraday Stock Signals - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Harvard Bioscience Inc. stock daily chart insights2-Day Signal Watch with Forecast Outcome - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Harvard Bioscience Inc. stock outlook for YEARStock Entry Points Based on Technicals - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Why Harvard Bioscience Inc. stock attracts strong analyst attentionFree Real Time Alerts Based on AI Prediction - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Relative strength of Harvard Bioscience Inc. in sector analysisFree Alert Feed for Momentum Based Picks - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What earnings revisions data tells us about Harvard Bioscience Inc.Free Weekly Potential Breakout Stock List - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Harvard Bioscience Inc. stock poised for growthReal Chart Based Opportunity Identification - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Real time scanner hits for Harvard Bioscience Inc. explainedFree Proven Entry Plan With Low Risk Trade - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Harvard Bioscience HBIO 2025Q2 Earnings Preview Upside Anticipated on Innovative Gene Therapy Developments - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Harvard Bioscience Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Chart overlay techniques for tracking Harvard Bioscience Inc.AI Intraday Market Movement Prediction Tool - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Harvard Bioscience Enters Sixth Amendment To Credit Agreement; Lenders Agree Not To Test Financial Covenants For Q3 2025; Agrees To Pay $400K Fees To Lenders; Explores Alternative Capital Sources For Refinancing; Says There Is Substantial Doubt - 富途牛牛

Aug 08, 2025
pulisher
Aug 06, 2025

Harvard Bioscience announces CEO succession plan - MSN

Aug 06, 2025
pulisher
Aug 05, 2025

Harvard Bioscience Sets Q2 2025 Earnings Release and Conference Call - AInvest

Aug 05, 2025
pulisher
Aug 04, 2025

Harvard Bioscience, Inc. to Release Q2 2025 Financial Results and Host Conference Call on August 11, 2025 - Quiver Quantitative

Aug 04, 2025
pulisher
Aug 04, 2025

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewswire

Aug 04, 2025
pulisher
Aug 04, 2025

Harvard Bioscience Upcoming Q2 2025 Earnings: Pre-Market Release and Conference Call Details Revealed - Stock Titan

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 19:22:29 - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Using R and stats models for Harvard Bioscience Inc. forecastingFree Capital Growth With Controlled Risk Picks - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

Harvard Bioscience Inc. Stock Analysis and ForecastInvest confidently with professional market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Harvard Bioscience Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Harvard Bioscience Inc. stock price move sharplyPhenomenal trading returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Harvard Bioscience Inc. stock overvalued or undervaluedUnlock exclusive trading tools and resources - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Harvard Bioscience Inc. stock priceBuild a portfolio for long-term financial success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Harvard Bioscience Inc. stock compared to the marketUnlock your portfolio’s hidden potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Harvard Bioscience Inc. company’s growth strategyPowerful market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Harvard Bioscience Inc. a growth stock or a value stockFree Capital Allocation Plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Harvard Bioscience Inc. compare to its industry peersBuild a diversified portfolio for risk mitigation - Jammu Links News

Aug 03, 2025

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$139.07
price up icon 3.15%
medical_instruments_supplies BAX
$23.98
price up icon 2.17%
$72.15
price up icon 0.08%
medical_instruments_supplies COO
$72.12
price up icon 1.76%
$67.61
price down icon 0.54%
medical_instruments_supplies WST
$238.74
price down icon 0.69%
Kapitalisierung:     |  Volumen (24h):